Industry Research Reports

Home > Reports > Medical Devices & Consumables > AI Cardiovascular Imaging- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

AI Cardiovascular Imaging- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Medical Devices & Consumables

Published Date: 2024-12-29

Pages: 93 Pages

Report ld: 3414481

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

AI Cardiovascular Imaging Market Size(US$)

CAGR 2024-2030

12.7%

Market Size,2030

USD 2,172

Million

Market Snapshot

Market Size in 2024 (Value)

US$ 1,060 million

Market Forecast in 2030(Value)

US$ 2,172 million

CAGR

12.7%

Years Considered

2019-2030

Base Year

2024

Forecast Period

2024-2030

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for AI Cardiovascular Imaging was estimated to be worth US$ 930 million in 2023 and is forecast to a readjusted size of US$ 2172 million by 2030 with a CAGR of 12.7% during the forecast period 2024-2030.

AI Cardiovascular Imaging refers to the use of artificial intelligence technology to analyze and process cardiovascular imaging data to assist doctors in faster and more accurate diagnosis, treatment planning and disease monitoring. This technology can improve the efficiency of the interpretation of cardiovascular images, reduce the workload of doctors, and may detect subtle abnormalities that are difficult for humans to recognize, thereby improving patient outcomes and outcomes

North American market for AI Cardiovascular Imaging was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for AI Cardiovascular Imaging was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for AI Cardiovascular Imaging was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of AI Cardiovascular Imaging include Cleerly, Inc, CathWorks, Ultromics Limited, Idoven, Arterys Inc., Philips, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

The AI Cardiovascular Imaging market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding AI Cardiovascular Imaging.

MARKET SEGMENTATION

By Company

Cleerly, Inc
CathWorks
Ultromics Limited
Idoven
Arterys Inc.
Philips

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Ai-assisted Diagnostic System
3D Image Reconstruction Technology
Automated Image Analysis
Others

Segment by Application

Hospital
Ambulatory Surgery Centers
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of AI Cardiovascular Imaging company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of AI Cardiovascular Imaging in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of AI Cardiovascular Imaging in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 AI Cardiovascular Imaging Product Introduction

1.2 Global AI Cardiovascular Imaging Market Size Forecast (2019-2030)

1.3 AI Cardiovascular Imaging Market Trends & Drivers

1.3.1 AI Cardiovascular Imaging Industry Trends

1.3.2 AI Cardiovascular Imaging Market Drivers & Opportunity

1.3.3 AI Cardiovascular Imaging Market Challenges

1.3.4 AI Cardiovascular Imaging Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global AI Cardiovascular Imaging Players Revenue Ranking (2023)

2.2 Global AI Cardiovascular Imaging Revenue by Company (2019-2024)

2.3 Key Companies AI Cardiovascular Imaging Manufacturing Base Distribution and Headquarters

2.4 Key Companies AI Cardiovascular Imaging Product Offered

2.5 Key Companies Time to Begin Mass Production of AI Cardiovascular Imaging

2.6 AI Cardiovascular Imaging Market Competitive Analysis

2.6.1 AI Cardiovascular Imaging Market Concentration Rate (2019-2024)

2.6.2 Global 5 and 10 Largest Companies by AI Cardiovascular Imaging Revenue in 2023

2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Cardiovascular Imaging as of 2023)

2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Ai-assisted Diagnostic System

3.1.2 3D Image Reconstruction Technology

3.1.3 Automated Image Analysis

3.1.4 Others

3.2 Global AI Cardiovascular Imaging Sales Value by Type

3.2.1 Global AI Cardiovascular Imaging Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global AI Cardiovascular Imaging Sales Value, by Type (2019-2030)

3.2.3 Global AI Cardiovascular Imaging Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Ambulatory Surgery Centers

4.1.3 Others

4.2 Global AI Cardiovascular Imaging Sales Value by Application

4.2.1 Global AI Cardiovascular Imaging Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global AI Cardiovascular Imaging Sales Value, by Application (2019-2030)

4.2.3 Global AI Cardiovascular Imaging Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

5.1 Global AI Cardiovascular Imaging Sales Value by Region

5.1.1 Global AI Cardiovascular Imaging Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global AI Cardiovascular Imaging Sales Value by Region (2019-2024)

5.1.3 Global AI Cardiovascular Imaging Sales Value by Region (2025-2030)

5.1.4 Global AI Cardiovascular Imaging Sales Value by Region (%), (2019-2030)

5.2 North America

5.2.1 North America AI Cardiovascular Imaging Sales Value, 2019-2030

5.2.2 North America AI Cardiovascular Imaging Sales Value by Country (%), 2023 VS 2030

5.3 Europe

5.3.1 Europe AI Cardiovascular Imaging Sales Value, 2019-2030

5.3.2 Europe AI Cardiovascular Imaging Sales Value by Country (%), 2023 VS 2030

5.4 Asia Pacific

5.4.1 Asia Pacific AI Cardiovascular Imaging Sales Value, 2019-2030

5.4.2 Asia Pacific AI Cardiovascular Imaging Sales Value by Region (%), 2023 VS 2030

5.5 South America

5.5.1 South America AI Cardiovascular Imaging Sales Value, 2019-2030

5.5.2 South America AI Cardiovascular Imaging Sales Value by Country (%), 2023 VS 2030

5.6 Middle East & Africa

5.6.1 Middle East & Africa AI Cardiovascular Imaging Sales Value, 2019-2030

5.6.2 Middle East & Africa AI Cardiovascular Imaging Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions AI Cardiovascular Imaging Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions AI Cardiovascular Imaging Sales Value, 2019-2030

6.3 United States

6.3.1 United States AI Cardiovascular Imaging Sales Value, 2019-2030

6.3.2 United States AI Cardiovascular Imaging Sales Value by Type (%), 2023 VS 2030

6.3.3 United States AI Cardiovascular Imaging Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe AI Cardiovascular Imaging Sales Value, 2019-2030

6.4.2 Europe AI Cardiovascular Imaging Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe AI Cardiovascular Imaging Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China AI Cardiovascular Imaging Sales Value, 2019-2030

6.5.2 China AI Cardiovascular Imaging Sales Value by Type (%), 2023 VS 2030

6.5.3 China AI Cardiovascular Imaging Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan AI Cardiovascular Imaging Sales Value, 2019-2030

6.6.2 Japan AI Cardiovascular Imaging Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan AI Cardiovascular Imaging Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea AI Cardiovascular Imaging Sales Value, 2019-2030

6.7.2 South Korea AI Cardiovascular Imaging Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea AI Cardiovascular Imaging Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia AI Cardiovascular Imaging Sales Value, 2019-2030

6.8.2 Southeast Asia AI Cardiovascular Imaging Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia AI Cardiovascular Imaging Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India AI Cardiovascular Imaging Sales Value, 2019-2030

6.9.2 India AI Cardiovascular Imaging Sales Value by Type (%), 2023 VS 2030

6.9.3 India AI Cardiovascular Imaging Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Cleerly, Inc

7.1.1 Cleerly, Inc Profile

7.1.2 Cleerly, Inc Main Business

7.1.3 Cleerly, Inc AI Cardiovascular Imaging Products, Services and Solutions

7.1.4 Cleerly, Inc AI Cardiovascular Imaging Revenue (US$ Million) & (2019-2024)

7.1.5 Cleerly, Inc Recent Developments

7.2 CathWorks

7.2.1 CathWorks Profile

7.2.2 CathWorks Main Business

7.2.3 CathWorks AI Cardiovascular Imaging Products, Services and Solutions

7.2.4 CathWorks AI Cardiovascular Imaging Revenue (US$ Million) & (2019-2024)

7.2.5 CathWorks Recent Developments

7.3 Ultromics Limited

7.3.1 Ultromics Limited Profile

7.3.2 Ultromics Limited Main Business

7.3.3 Ultromics Limited AI Cardiovascular Imaging Products, Services and Solutions

7.3.4 Ultromics Limited AI Cardiovascular Imaging Revenue (US$ Million) & (2019-2024)

7.3.5 Ultromics Limited Recent Developments

7.4 Idoven

7.4.1 Idoven Profile

7.4.2 Idoven Main Business

7.4.3 Idoven AI Cardiovascular Imaging Products, Services and Solutions

7.4.4 Idoven AI Cardiovascular Imaging Revenue (US$ Million) & (2019-2024)

7.4.5 Idoven Recent Developments

7.5 Arterys Inc.

7.5.1 Arterys Inc. Profile

7.5.2 Arterys Inc. Main Business

7.5.3 Arterys Inc. AI Cardiovascular Imaging Products, Services and Solutions

7.5.4 Arterys Inc. AI Cardiovascular Imaging Revenue (US$ Million) & (2019-2024)

7.5.5 Arterys Inc. Recent Developments

7.6 Philips

7.6.1 Philips Profile

7.6.2 Philips Main Business

7.6.3 Philips AI Cardiovascular Imaging Products, Services and Solutions

7.6.4 Philips AI Cardiovascular Imaging Revenue (US$ Million) & (2019-2024)

7.6.5 Philips Recent Developments

8 Industry Chain Analysis

8.1 AI Cardiovascular Imaging Industrial Chain

8.2 AI Cardiovascular Imaging Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 AI Cardiovascular Imaging Sales Model

8.5.2 Sales Channel

8.5.3 AI Cardiovascular Imaging Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. AI Cardiovascular Imaging Market Trends

Table 2. AI Cardiovascular Imaging Market Drivers & Opportunity

Table 3. AI Cardiovascular Imaging Market Challenges

Table 4. AI Cardiovascular Imaging Market Restraints

Table 5. Global AI Cardiovascular Imaging Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global AI Cardiovascular Imaging Revenue Market Share by Company (2019-2024)

Table 7. Key Companies AI Cardiovascular Imaging Manufacturing Base Distribution and Headquarters

Table 8. Key Companies AI Cardiovascular Imaging Product Type

Table 9. Key Companies Time to Begin Mass Production of AI Cardiovascular Imaging

Table 10. Global AI Cardiovascular Imaging Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI Cardiovascular Imaging as of 2023)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global AI Cardiovascular Imaging Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 14. Global AI Cardiovascular Imaging Sales Value by Type (2019-2024) & (US$ Million)

Table 15. Global AI Cardiovascular Imaging Sales Value by Type (2025-2030) & (US$ Million)

Table 16. Global AI Cardiovascular Imaging Sales Market Share in Value by Type (2019-2024)

Table 17. Global AI Cardiovascular Imaging Sales Market Share in Value by Type (2025-2030)

Table 18. Global AI Cardiovascular Imaging Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 19. Global AI Cardiovascular Imaging Sales Value by Application (2019-2024) & (US$ Million)

Table 20. Global AI Cardiovascular Imaging Sales Value by Application (2025-2030) & (US$ Million)

Table 21. Global AI Cardiovascular Imaging Sales Market Share in Value by Application (2019-2024)

Table 22. Global AI Cardiovascular Imaging Sales Market Share in Value by Application (2025-2030)

Table 23. Global AI Cardiovascular Imaging Sales Value by Region, (2019 VS 2023 VS 2030) & (US$ Million)

Table 24. Global AI Cardiovascular Imaging Sales Value by Region (2019-2024) & (US$ Million)

Table 25. Global AI Cardiovascular Imaging Sales Value by Region (2025-2030) & (US$ Million)

Table 26. Global AI Cardiovascular Imaging Sales Value by Region (2019-2024) & (%)

Table 27. Global AI Cardiovascular Imaging Sales Value by Region (2025-2030) & (%)

Table 28. Key Countries/Regions AI Cardiovascular Imaging Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 29. Key Countries/Regions AI Cardiovascular Imaging Sales Value, (2019-2024) & (US$ Million)

Table 30. Key Countries/Regions AI Cardiovascular Imaging Sales Value, (2025-2030) & (US$ Million)

Table 31. Cleerly, Inc Basic Information List

Table 32. Cleerly, Inc Description and Business Overview

Table 33. Cleerly, Inc AI Cardiovascular Imaging Products, Services and Solutions

Table 34. Revenue (US$ Million) in AI Cardiovascular Imaging Business of Cleerly, Inc (2019-2024)

Table 35. Cleerly, Inc Recent Developments

Table 36. CathWorks Basic Information List

Table 37. CathWorks Description and Business Overview

Table 38. CathWorks AI Cardiovascular Imaging Products, Services and Solutions

Table 39. Revenue (US$ Million) in AI Cardiovascular Imaging Business of CathWorks (2019-2024)

Table 40. CathWorks Recent Developments

Table 41. Ultromics Limited Basic Information List

Table 42. Ultromics Limited Description and Business Overview

Table 43. Ultromics Limited AI Cardiovascular Imaging Products, Services and Solutions

Table 44. Revenue (US$ Million) in AI Cardiovascular Imaging Business of Ultromics Limited (2019-2024)

Table 45. Ultromics Limited Recent Developments

Table 46. Idoven Basic Information List

Table 47. Idoven Description and Business Overview

Table 48. Idoven AI Cardiovascular Imaging Products, Services and Solutions

Table 49. Revenue (US$ Million) in AI Cardiovascular Imaging Business of Idoven (2019-2024)

Table 50. Idoven Recent Developments

Table 51. Arterys Inc. Basic Information List

Table 52. Arterys Inc. Description and Business Overview

Table 53. Arterys Inc. AI Cardiovascular Imaging Products, Services and Solutions

Table 54. Revenue (US$ Million) in AI Cardiovascular Imaging Business of Arterys Inc. (2019-2024)

Table 55. Arterys Inc. Recent Developments

Table 56. Philips Basic Information List

Table 57. Philips Description and Business Overview

Table 58. Philips AI Cardiovascular Imaging Products, Services and Solutions

Table 59. Revenue (US$ Million) in AI Cardiovascular Imaging Business of Philips (2019-2024)

Table 60. Philips Recent Developments

Table 61. Key Raw Materials Lists

Table 62. Raw Materials Key Suppliers Lists

Table 63. AI Cardiovascular Imaging Downstream Customers

Table 64. AI Cardiovascular Imaging Distributors List

Table 65. Research Programs/Design for This Report

Table 66. Key Data Information from Secondary Sources

Table 67. Key Data Information from Primary Sources

Table 68. Business Unit and Senior & Team Lead Analysts

List of Figures

Figure 1. AI Cardiovascular Imaging Product Picture

Figure 2. Global AI Cardiovascular Imaging Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global AI Cardiovascular Imaging Sales Value (2019-2030) & (US$ Million)

Figure 4. AI Cardiovascular Imaging Report Years Considered

Figure 5. Global AI Cardiovascular Imaging Players Revenue Ranking (2023) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by AI Cardiovascular Imaging Revenue in 2023

Figure 7. AI Cardiovascular Imaging Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 8. Ai-assisted Diagnostic System Picture

Figure 9. 3D Image Reconstruction Technology Picture

Figure 10. Automated Image Analysis Picture

Figure 11. Others Picture

Figure 12. Global AI Cardiovascular Imaging Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 13. Global AI Cardiovascular Imaging Sales Value Market Share by Type, 2023 & 2030

Figure 14. Product Picture of Hospital

Figure 15. Product Picture of Ambulatory Surgery Centers

Figure 16. Product Picture of Others

Figure 17. Global AI Cardiovascular Imaging Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 18. Global AI Cardiovascular Imaging Sales Value Market Share by Application, 2023 & 2030

Figure 19. North America AI Cardiovascular Imaging Sales Value (2019-2030) & (US$ Million)

Figure 20. North America AI Cardiovascular Imaging Sales Value by Country (%), 2023 VS 2030

Figure 21. Europe AI Cardiovascular Imaging Sales Value, (2019-2030) & (US$ Million)

Figure 22. Europe AI Cardiovascular Imaging Sales Value by Country (%), 2023 VS 2030

Figure 23. Asia Pacific AI Cardiovascular Imaging Sales Value, (2019-2030) & (US$ Million)

Figure 24. Asia Pacific AI Cardiovascular Imaging Sales Value by Region (%), 2023 VS 2030

Figure 25. South America AI Cardiovascular Imaging Sales Value, (2019-2030) & (US$ Million)

Figure 26. South America AI Cardiovascular Imaging Sales Value by Country (%), 2023 VS 2030

Figure 27. Middle East & Africa AI Cardiovascular Imaging Sales Value, (2019-2030) & (US$ Million)

Figure 28. Middle East & Africa AI Cardiovascular Imaging Sales Value by Country (%), 2023 VS 2030

Figure 29. Key Countries/Regions AI Cardiovascular Imaging Sales Value (%), (2019-2030)

Figure 30. United States AI Cardiovascular Imaging Sales Value, (2019-2030) & (US$ Million)

Figure 31. United States AI Cardiovascular Imaging Sales Value by Type (%), 2023 VS 2030

Figure 32. United States AI Cardiovascular Imaging Sales Value by Application (%), 2023 VS 2030

Figure 33. Europe AI Cardiovascular Imaging Sales Value, (2019-2030) & (US$ Million)

Figure 34. Europe AI Cardiovascular Imaging Sales Value by Type (%), 2023 VS 2030

Figure 35. Europe AI Cardiovascular Imaging Sales Value by Application (%), 2023 VS 2030

Figure 36. China AI Cardiovascular Imaging Sales Value, (2019-2030) & (US$ Million)

Figure 37. China AI Cardiovascular Imaging Sales Value by Type (%), 2023 VS 2030

Figure 38. China AI Cardiovascular Imaging Sales Value by Application (%), 2023 VS 2030

Figure 39. Japan AI Cardiovascular Imaging Sales Value, (2019-2030) & (US$ Million)

Figure 40. Japan AI Cardiovascular Imaging Sales Value by Type (%), 2023 VS 2030

Figure 41. Japan AI Cardiovascular Imaging Sales Value by Application (%), 2023 VS 2030

Figure 42. South Korea AI Cardiovascular Imaging Sales Value, (2019-2030) & (US$ Million)

Figure 43. South Korea AI Cardiovascular Imaging Sales Value by Type (%), 2023 VS 2030

Figure 44. South Korea AI Cardiovascular Imaging Sales Value by Application (%), 2023 VS 2030

Figure 45. Southeast Asia AI Cardiovascular Imaging Sales Value, (2019-2030) & (US$ Million)

Figure 46. Southeast Asia AI Cardiovascular Imaging Sales Value by Type (%), 2023 VS 2030

Figure 47. Southeast Asia AI Cardiovascular Imaging Sales Value by Application (%), 2023 VS 2030

Figure 48. India AI Cardiovascular Imaging Sales Value, (2019-2030) & (US$ Million)

Figure 49. India AI Cardiovascular Imaging Sales Value by Type (%), 2023 VS 2030

Figure 50. India AI Cardiovascular Imaging Sales Value by Application (%), 2023 VS 2030

Figure 51. AI Cardiovascular Imaging Industrial Chain

Figure 52. AI Cardiovascular Imaging Manufacturing Cost Structure

Figure 53. Channels of Distribution (Direct Sales, and Distribution)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global AI Cardiovascular Imaging market? zhanKai

The top companies in the global AI Cardiovascular Imaging market are Cleerly, Inc、CathWorks、Ultromics Limited.

Which region is expected to have the highest market share? shouQi

What is the annual compound growth rate of the global AI Cardiovascular Imaging market size from 2024 to 2030? shouQi

What was the global market size of AI Cardiovascular Imaging in 2024? shouQi

What was the global market size of AI Cardiovascular Imaging in 2030? shouQi

Related Reports

Global AI Cardiovascular Imaging Market Outlook, In‑Depth Analysis & Forecast to 2032
The global AI Cardiovascular Imaging market is projected to grow from US$ 1181 million in 2025 to US$ 2697 million by 2032, at a CAGR of 12.7% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-24
Pages: 123
USD 4900.00
(Single User License)
Global AI Cardiovascular Imaging Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AI Cardiovascular Imaging market size was US$ 1181 million in 2025 and is forecast to reach a readjusted size of US$ 2697 million by 2032 with a CAGR of 12.7% during the forecast period 2026-2032.
Published Date: 2026-03-24
Pages: 79
USD 4250.00
(Single User License)
AI Cardiovascular Imaging - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI Cardiovascular Imaging was estimated to be worth US$ 1181 million in 2025 and is projected to reach US$ 2697 million, growing at a CAGR of 12.7% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 95
USD 3950.00
(Single User License)
Global AI Cardiovascular Imaging Market Research Report 2026
The global AI Cardiovascular Imaging market was valued at US$ 1181 million in 2025 and is anticipated to reach US$ 2697 million by 2032, at a CAGR of 12.7% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 109
USD 2900.00
(Single User License)
Global AI Cardiovascular Imaging Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI Cardiovascular Imaging market size was US$ 1060 million in 2024 and is forecast to a readjusted size of US$ 2420 million by 2031 with a CAGR of 12.7% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 80
USD 4250.00
(Single User License)
Global AI Cardiovascular Imaging Market Outlook, In‑Depth Analysis & Forecast to 2031
The global AI Cardiovascular Imaging market is projected to grow from US$ 1060 million in 2024 to US$ 2420 million by 2031, at a CAGR of 12.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-07-31
Pages: 118
USD 4900.00
(Single User License)
AI Cardiovascular Imaging - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for AI Cardiovascular Imaging was estimated to be worth US$ 1060 million in 2024 and is forecast to a readjusted size of US$ 2420 million by 2031 with a CAGR of 12.7% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 89
USD 3950.00
(Single User License)
Global AI Cardiovascular Imaging Market Research Report 2025
The global market for AI Cardiovascular Imaging was valued at US$ 1060 million in the year 2024 and is projected to reach a revised size of US$ 2420 million by 2031, growing at a CAGR of 12.7% during the forecast period.
Published Date: 2025-03-10
Pages: 77
USD 2900.00
(Single User License)
Global AI Cardiovascular Imaging Market Insights, Forecast to 2030
Valued at US$ 1060 million in 2024, the global AI Cardiovascular Imaging market is forecast to reach US$ 2172 million by 2030, at a CAGR of 12.7% during the forecast period.
Published Date: 2024-12-29
Pages: 124
USD 4900.00
(Single User License)
Global and United States AI Cardiovascular Imaging Market Report & Forecast 2024-2030
The global AI Cardiovascular Imaging revenue was US$ 930 million in 2023 and is forecast to a readjusted size of US$ 2172 million by 2030 with a CAGR of 12.7% during the review period (2024-2030).
Published Date: 2024-12-29
Pages: 97
USD 4350.00
(Single User License)

Global AI Cardiovascular Imaging Market Outlook, In‑Depth Analysis & Forecast to 2032
The global AI Cardiovascular Imaging market is projected to grow from US$ 1181 million in 2025 to US$ 2697 million by 2032, at a CAGR of 12.7% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-24
Pages: 123
USD 4900.00 (Single User License)
Global AI Cardiovascular Imaging Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AI Cardiovascular Imaging market size was US$ 1181 million in 2025 and is forecast to reach a readjusted size of US$ 2697 million by 2032 with a CAGR of 12.7% during the forecast period 2026-2032.
Published: 2026-03-24
Pages: 79
USD 4250.00 (Single User License)
AI Cardiovascular Imaging - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI Cardiovascular Imaging was estimated to be worth US$ 1181 million in 2025 and is projected to reach US$ 2697 million, growing at a CAGR of 12.7% from 2026 to 2032.
Published: 2026-01-19
Pages: 95
USD 3950.00 (Single User License)
Global AI Cardiovascular Imaging Market Research Report 2026
The global AI Cardiovascular Imaging market was valued at US$ 1181 million in 2025 and is anticipated to reach US$ 2697 million by 2032, at a CAGR of 12.7% from 2026 to 2032.
Published: 2026-01-08
Pages: 109
USD 2900.00 (Single User License)
Global AI Cardiovascular Imaging Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global AI Cardiovascular Imaging market size was US$ 1060 million in 2024 and is forecast to a readjusted size of US$ 2420 million by 2031 with a CAGR of 12.7% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 80
USD 4250.00 (Single User License)
Global AI Cardiovascular Imaging Market Outlook, In‑Depth Analysis & Forecast to 2031
The global AI Cardiovascular Imaging market is projected to grow from US$ 1060 million in 2024 to US$ 2420 million by 2031, at a CAGR of 12.7% (2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-07-31
Pages: 118
USD 4900.00 (Single User License)
AI Cardiovascular Imaging - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for AI Cardiovascular Imaging was estimated to be worth US$ 1060 million in 2024 and is forecast to a readjusted size of US$ 2420 million by 2031 with a CAGR of 12.7% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 89
USD 3950.00 (Single User License)
Global AI Cardiovascular Imaging Market Research Report 2025
The global market for AI Cardiovascular Imaging was valued at US$ 1060 million in the year 2024 and is projected to reach a revised size of US$ 2420 million by 2031, growing at a CAGR of 12.7% during the forecast period.
Published: 2025-03-10
Pages: 77
USD 2900.00 (Single User License)
Global AI Cardiovascular Imaging Market Insights, Forecast to 2030
Valued at US$ 1060 million in 2024, the global AI Cardiovascular Imaging market is forecast to reach US$ 2172 million by 2030, at a CAGR of 12.7% during the forecast period.
Published: 2024-12-29
Pages: 124
USD 4900.00 (Single User License)
Global and United States AI Cardiovascular Imaging Market Report & Forecast 2024-2030
The global AI Cardiovascular Imaging revenue was US$ 930 million in 2023 and is forecast to a readjusted size of US$ 2172 million by 2030 with a CAGR of 12.7% during the review period (2024-2030).
Published: 2024-12-29
Pages: 97
USD 4350.00 (Single User License)